Biotech Investors & VC Firms
2107 firms in this list, with a median first check of $500K. 405 of them lead rounds. Generated from verified public data and updated continuously.
Worthwhile Industries Campuses
TorontoLate Stage
Israel Biotech Fund
RehovotSeed–Series A
5 people
New Leaf Venture Partners
New YorkSeed–Late Stage
5 people
Crista Galli Ventures
LondonPre-Seed–Series A
E15
Hong KongPre-Seed–Late Stage
Egora Holding
MartinsriedPre-Seed–Late Stage$5.4M
GERBER-RAUTH
MilanPre-Seed–Late Stage
HaloHealth
TorontoPre-Seed–Series A
National Science Foundation
Alexandria
Praetura Ventures
ManchesterSeed–Series A
Anais Ventures
LancySeries A–Series C
3 people
Boxer Capital, LLC
San DiegoSeed–Late Stage
Chemelot Ventures
Seed–Late Stage
Excell Partners
RochesterPre-Seed–Series A$100K – $500K
3 people
IKJ Capital
Palo AltoPre-Seed–Series A
JAFCO Group
TokyoPre-Seed–Late Stage$1.9M – $198M
KU Leuven Research & Development
Pre-Seed
Mass General Brigham Ventures
BostonSeed–Series A
Nventure
CobourgSeed–Series A$182.5K
RMGP Biopharma Investment Fund
HerzliyaSeed–Series A
6 people
RUSNANO
MoscowSeed–Late Stage
Stonebridge Ventures
SeoulSeed–Late Stage$743K – $33M
3 people
The Ganesha Fund
SantiagoPre-Seed–Seed
Trinity Capital
PhoenixGrowth
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.








